or Try an Advanced Search...

    Technical Analysis for SAVA - Cassava Sciences, Inc.

    Grade Last Price % Change Price Change
    B 22.25 -0.40% -0.09
    SAVA closed up 2.81 percent on Friday, April 26, 2024, on 1.35 times normal volume.
    Earnings due: Apr 29
    *** please verify all earnings dates ***
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical SAVA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion -0.40%
    Up 3 Days in a Row Strength -0.40%
    Up 4 Days in a Row Strength -0.40%
    Up 5 Days in a Row Strength -0.40%
    Crossed Above 20 DMA Bullish 2.39%
    Crossed Above 200 DMA Bullish 2.39%
    Crossed Above 50 DMA Bullish 2.39%
    Wide Bands Range Expansion 2.39%
    Up 3 Days in a Row Strength 2.39%
    Up 4 Days in a Row Strength 2.39%
    Older End-of-Day Signals for SAVA ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 4 hours ago
    Rose Above Previous Day's High about 4 hours ago
    60 Minute Opening Range Breakout 3 days ago
    Up 3% 3 days ago
    Possible NR7 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SAVA Chart by TradingView
    Basic chart:

    Profile

    Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Transdermal Abnormal Psychology

    Is SAVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 15 Redemption Date Announced for Warrants
    Mar 25 Cassava Sciences: New Year, Same Game Of Smoke And Mirrors
    Mar 25 Cassava Alzheimer's candidate simufilam clears phase 3 safety review
    Mar 25 Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
    Mar 17 Cassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go?
    Mar 12 Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
    Mar 12 Boeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Mar 11 Cassava Sciences again under scrutiny over Alzheimer's drug research
    Mar 6 Bullish Cassava Sciences Insiders Loaded Up On US$3.12m Of Stock
    Mar 4 Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
    See more SAVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 32.1
    52 Week Low 12.3202
    Average Volume 796,796
    200-Day Moving Average 21.30
    50-Day Moving Average 21.50
    20-Day Moving Average 21.69
    10-Day Moving Average 20.90
    Average True Range 1.43
    RSI (14) 53.70
    ADX 12.96
    +DI 27.32
    -DI 22.19
    Chandelier Exit (Long, 3 ATRs) 22.39
    Chandelier Exit (Short, 3 ATRs) 23.73
    Upper Bollinger Bands 25.33
    Lower Bollinger Band 18.04
    Percent B (%b) 0.59
    BandWidth 33.65
    MACD Line -0.08
    MACD Signal Line -0.08
    MACD Histogram -0.0051
    Fundamentals Value
    Market Cap 943.57 Million
    Num Shares 42.2 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -9.76
    Price-to-Sales 0.00
    Price-to-Book 6.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.50
    Resistance 3 (R3) 23.41 22.93 23.30
    Resistance 2 (R2) 22.93 22.64 22.98 23.24
    Resistance 1 (R1) 22.64 22.46 22.79 22.73 23.17
    Pivot Point 22.16 22.16 22.24 22.21 22.16
    Support 1 (S1) 21.87 21.87 22.02 21.96 21.51
    Support 2 (S2) 21.39 21.69 21.44 21.44
    Support 3 (S3) 21.10 21.39 21.38
    Support 4 (S4) 21.19